Notes
DAILY RECAP
**BYD Co. ( $BYDDF)** reported a 67.8% y/y increase in November vehicle sales, reaching 506,804 units compared to 301,903 last year. Year-to-date sales hit 3.76M units, up from 2.68M last year.
**Gap ( $GAP)** received an upgrade to overweight from neutral by JPMorgan after a CEO and CFO meeting.
**Li Auto Inc. ( $LI)** delivered 48,740 vehicles in November 2024, a y/y increase of 18.8%, with a 2024 total of 441,995 and cumulative deliveries at 1,075,359.
**NIO Inc. ( $NIO)** saw a 28.9% y/y rise in November deliveries to 20,575 vehicles, split between its NIO and ONVO brands.
**Stellantis ( $STLA)** announced CEO Carlos Tavares' resignation, effective immediately, with a new CEO search set to conclude in 2025's first half.
**XPeng Inc. ( $XPEV)** delivered 30,895 Smart EVs in November, up 54% y/y and 29% m/m, with strong sales of the MONA M03 and P7+.
**Core Scientific Inc. ( $CORZ)** plans to issue $500M in convertible senior notes maturing in 2031.
**IREN Limited ( $IREN)** boosted its self-mining capacity by 33% to 28 EH/s with new substation energization.
**LendingClub ( $LC)** was downgraded to neutral by JPMorgan due to fintech sector concerns.
**Mara Holdings ( $MARA)** is set to offer $700M in zero-coupon convertible senior notes privately.
**Toast ( $TOST)** received a downgrade to Neutral from Goldman Sachs, citing high valuation and visibility issues.
**Upstart Holdings ( $UPST)** was downgraded to underweight by JP Morgan.
**Bausch + Lomb ( $BLCO)** was downgraded to Equal Weight by Morgan Stanley.
**Nevro ( $NVRO)** saw a downgrade to Underweight by Morgan Stanley.
**Tandem Diabetes ( $TNDM)** got an upgrade to Overweight from Morgan Stanley.
**Cloudflare ( $NET)** was upgraded to overweight by Morgan Stanley, optimistic about future growth.
**SentinelOne ( $S)** was downgraded to equal weight by Morgan Stanley, due to cybersecurity sector concerns.
**U.S. to implement new export restrictions on Monday targeting China's semiconductor sector**, affecting companies like Naura Technology Group, potentially impacting shares of $AMAT, $LRCX, $KLAC.
RECAP
• $HD: Q3 EPS $3.78 vs. $3.65 est., revenue up 6.6% to $40.22B. Comp sales down 1.3%, better than expected. Raised FY24 sales forecast to 4% growth.
• $BABA: Strong sales growth during Singles' Day, 45 brands hit over 1 billion yuan GMV.
• $LYV: Q3 operating income $909.8M vs. $856.6M est., revenue down 6.2% to $7.65B. Ticket sales for 2024 up 3%.
• $ONON: Q3 EPS CHF 0.16, below est. CHF 0.20. Sales CHF 635.8M, up from expected CHF 617.3M. Increased FY sales forecast.
• $VIK: Upgraded by Morgan Stanley due to robust cruise demand.
• $APAM: AUM as of October 31, 2024, was $162.8B, with $78.8B in Artisan Funds and $84.0B in other accounts.
• $AGO: Q3 EPS $2.42 vs. $1.42 est., revenue down 33% to $269M, premiums up 53% to $61M.
• $CNS: AUM decreased to $89.7B by October 31, 2024, from $91.8B, due to market depreciation and distributions.
• $IVZ: AUM dropped to $1.772T, down 1.3%, with $2B in net inflows but losses from market returns.
• $JRVR: Q3 premiums grew 6%, with a high combined ratio of 136.1% but a better current year ratio at 92.6%.
• $RMR: Q4 EPS $0.34 below $0.40 est., EBITDA slightly above estimate at $21.8M.
• $HOOD: October showed 24.4M funded customers, $159.7B in assets, with significant growth in deposits.
• $VCTR: Reported AUM of $172.3B, total client assets of $176.5B for October 31, 2024.
• $ASRT: Q3 EPS $0.03 vs. ($0.05) est., EBITDA $5.3M vs. $4.7M est., revenue $29.2M vs. $28.87M est.
• $AZN: Upgraded full-year guidance due to strong Q3, expects high teens growth for earnings and revenue in 2024.
• $BAYRY: Stock dropped after forecasting lower earnings next year due to weak ag markets.
• $NGNE: Shares fell despite positive trial data for Rett Syndrome drug, due to an adverse event.
• $NVRO: Q3 EPS ($0.41) vs. ($0.81) est., improved EBITDA, raised FY revenue guidance.
• $STXS: Q3 EPS ($0.08) vs. ($0.05) est., revenue beat expectations, kept flat year-over-year revenue guidance.
IAC: Considering spinning off Angi, which IAC controls 85% of, valued at $1.25B, after exceeding Q3 revenue forecasts due to Dotdash Meredith.
• $IVAC: Q3 EPS loss was ($0.08) vs. ($0.15) est., revenue significantly beat estimates at $28.5M.
• $OKTA: Downgraded to hold by Deutsche Bank.
• $SE: Q3 EPS $0.24 missed estimates by $0.02, but revenue hit $4.3B, beating estimates.
• $ZETA: Q3 EBITDA $53.6M vs. $49.93M est., revenue $268M vs. $252.5M est., raised Q4 guidance.